Bugworks
is a California-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and infectious diseases... Read moreBugworks
is a California-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and infectious diseases... Read more
News
Jun 11, 2024
The Hindu
Bugworks: GARDP commits $20 million for Bugworks' innovative compound to fight MDR bacteria
Feb 22, 2024
SEC
Bugworks: Bugworks Research received $6.8M in Equity Funding
Dec 12, 2023
IndiaMedToday
Bugworks: Bugworks Research presents research findings on cancer drugs at European Society for Medical Oncology Immuno-Oncology Congress 2023, in Geneva, Switzerland
Jul 28, 2023
Contract Pharma
Bugworks: GARDP, Bugworks Partner to Accelerate Novel Antibiotic
Apr 17, 2023
FinanzNachrichten
Bugworks: Bugworks Research Inc. to Present Eight Posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, in Copenhagen, Denmark
Feb 23, 2023
IndiaMedToday
Bugworks: Bugworks Research appoints Dr Renu Swarup as honorary member of the Global Advisory Board
Sep 20, 2022
Pharmabiz
Bugworks: Bugworks Research and Cytecare Cancer Hospitals ink pact to propel development of immunooncology therapies
Jun 09, 2022
FirstWord Pharma
Bugworks: GARDP Supports Bugworks In Assessing Safety Of New Antibiotic Compound
Apr 25, 2022
The Economic Times
Bugworks: B'luru firm Bugworks begins work on drug against Covid-type viruses
Feb 09, 2022
Markets Insider
Bugworks: Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India
Bugworks Competitors
1
2
3
4
5
6
7
8
9
10